Novo Nordisk

Page 8 of 9

a box of wegovy injectables
Retail

Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports

By
November 13, 2023
Wegovy, an injectable prescription weight-loss medicine.
Health

A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’

By Madison Muller, Naomi Kresge and Bloomberg
November 11, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health

Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.

By
November 6, 2023
picture of four wegovy injections lined up
Health

Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

By
November 3, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health

Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.

By
November 2, 2023
Pepsico CEO Ramon Laguarta
Companies

Pepsi’s CEO is keeping an eye on weight-loss drugs, but shakes off fears voiced by Walmart that they could hurt the bottom line

By
October 11, 2023
ozempic injection picture
Finance

Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates

By
October 10, 2023
Wegovy shots seen in a factory setting.
Lifestyle

Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says

By
October 5, 2023
a picture of four wegovy injections
Finance

Drugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit

By
October 4, 2023
The theory that luxury stocks are Europe’s strongest response to Wall Street’s high-flying tech stocks is being put to the test

The theory that luxury stocks are Europe’s strongest response to Wall Street’s high-flying tech stocks is being put to the test

By Julien Ponthus, Michael Msika and Bloomberg
September 10, 2023
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive

By
December 6, 2021
Photo of CytoSeek CEO Carolyn Porter
Tech

New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells

By
March 16, 2021
FRANCE-POLITICS-INDUSTRY
Health

A Second Pharma Giant Just Promised to Ditch Crazy Drug Price Hikes

By
December 6, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership

This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again

By
October 12, 2016
Pharmaceutical Drug Roundup Inside A Pharmacy
International

The World’s Largest Insulin Maker Is Cutting 1,000 Jobs

By Reuters and Michelle Toh
September 29, 2016

Most Popular